Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (141-150 of 403) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2011
Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccinationJames B Wing, Lynne Smart, Ray Borrow, et al.
Vaccine|April 15, 2017
Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM<sub>197</sub>, DT and TT glycoconjugate vaccinesNicola J Beresford, Angela Martino, Ian M Feavers, et al.
Expert Review of Vaccines|December 15, 2015
Routinely vaccinating adolescents against meningococcus: targeting transmission & diseaseVolker Vetter, Roger Baxter, Gülhan Denizer, et al.
Emerging Infectious Diseases|December 25, 2012
Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and WalesShamez N Ladhani, Mary P E Slack, Nick J Andrews, et al.
Emerging Infectious Diseases|July 1, 2021
Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, EnglandSathyavani Subbarao, Helen Campbell, Sonia Ribeiro, et al.
The Journal of Infection|January 7, 2020
Invasive meningococcal disease: Timing and cause of death in England, 2008-2015Kazim Beebeejaun, Sydel R Parikh, Helen Campbell, et al.
Vaccine|September 11, 2022
Validation and use of a serum bactericidal antibody assay for Neisseria meningitidis serogroup X in a seroprevalence study in Niger, West AfricaSara Katz, Kelly Townsend-Payne, Jennifer Louth, et al.
Clinical and Vaccine Immunology : CVI|May 4, 2012
Immunogenicity and safety of a meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with one dose of bivalent and quadrivalent meningococcal polysaccharide vaccines: a phase III, controlled, randomized, and modified blind-observer studyYagob Al-Mazrou, Mohamed Khalil, Helen Findlow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2017
Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006-2014Godwin Oligbu, Sarah Collins, Carmen L Sheppard, et al.
The Pediatric Infectious Disease Journal|April 14, 2011
Immunoglobulin G deficiency in United kingdom children with invasive pneumococcal diseaseElaine Stanford, Shamez Ladhani, Ray Borrow, et al.
Pageof 41

Showing results (141-150 of 403) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 21, 2011
Kinetics of immune responses to nasal challenge with meningococcal polysaccharide one year after serogroup-C glycoconjugate vaccinationJames B Wing, Lynne Smart, Ray Borrow, et al.
Vaccine|April 15, 2017
Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM<sub>197</sub>, DT and TT glycoconjugate vaccinesNicola J Beresford, Angela Martino, Ian M Feavers, et al.
Expert Review of Vaccines|December 15, 2015
Routinely vaccinating adolescents against meningococcus: targeting transmission & diseaseVolker Vetter, Roger Baxter, Gülhan Denizer, et al.
Emerging Infectious Diseases|December 25, 2012
Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and WalesShamez N Ladhani, Mary P E Slack, Nick J Andrews, et al.
Emerging Infectious Diseases|July 1, 2021
Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, EnglandSathyavani Subbarao, Helen Campbell, Sonia Ribeiro, et al.
The Journal of Infection|January 7, 2020
Invasive meningococcal disease: Timing and cause of death in England, 2008-2015Kazim Beebeejaun, Sydel R Parikh, Helen Campbell, et al.
Vaccine|September 11, 2022
Validation and use of a serum bactericidal antibody assay for Neisseria meningitidis serogroup X in a seroprevalence study in Niger, West AfricaSara Katz, Kelly Townsend-Payne, Jennifer Louth, et al.
Clinical and Vaccine Immunology : CVI|May 4, 2012
Immunogenicity and safety of a meningococcal quadrivalent conjugate vaccine in Saudi Arabian adolescents previously vaccinated with one dose of bivalent and quadrivalent meningococcal polysaccharide vaccines: a phase III, controlled, randomized, and modified blind-observer studyYagob Al-Mazrou, Mohamed Khalil, Helen Findlow, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2017
Childhood Deaths Attributable to Invasive Pneumococcal Disease in England and Wales, 2006-2014Godwin Oligbu, Sarah Collins, Carmen L Sheppard, et al.
The Pediatric Infectious Disease Journal|April 14, 2011
Immunoglobulin G deficiency in United kingdom children with invasive pneumococcal diseaseElaine Stanford, Shamez Ladhani, Ray Borrow, et al.
Pageof 41